Yogeesha N Nayak, Deepika Dwarakanath, Keerthana Suresh Kizhakkanoodan, Rajeev K Sinha, K Sreedhara Ranganath Pai, Bharath Raja Guru, Santosh L Gaonkar
{"title":"吡啶-恶二唑衍生物的结构和抗癌性质：单晶XRD， Hirshfeld分析和对A549细胞的细胞毒性。","authors":"Yogeesha N Nayak, Deepika Dwarakanath, Keerthana Suresh Kizhakkanoodan, Rajeev K Sinha, K Sreedhara Ranganath Pai, Bharath Raja Guru, Santosh L Gaonkar","doi":"10.1021/acsomega.5c02152","DOIUrl":null,"url":null,"abstract":"<p><p>A new series of pyridine-based 1,3,4-oxadiazole derivatives was synthesized and structurally characterized using FTIR, NMR, HRMS, and single-crystal X-ray diffraction. Hirshfeld surface analysis of the meta-methyl-substituted derivative revealed key intermolecular interactions. Cytotoxicity was evaluated against A549 lung cancer cells via MTT assay, where compound <b>5k</b> (3,5-dichloro substitution) showed the highest activity (IC<sub>50</sub> = 6.99 ± 3.15 μM), comparable to 5-fluorouracil. Structure-activity relationship analysis indicated that meta-substituents enhance activity, while bulky or strongly electron-withdrawing groups reduce it. In silico studies demonstrated favorable ADME properties, and molecular docking with CDK2 revealed strong binding affinities. Molecular dynamics simulations confirmed the stability of the 5k-CDK2 complex over 100 ns. These findings suggest that pyridine-oxadiazole hybrids, particularly <b>5k</b>, are promising candidates for further development as anticancer agents.</p>","PeriodicalId":22,"journal":{"name":"ACS Omega","volume":"10 22","pages":"23549-23562"},"PeriodicalIF":4.3000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12163846/pdf/","citationCount":"0","resultStr":"{\"title\":\"Unraveling Structural and Anticancer Properties of Pyridine-Oxadiazole Derivatives: Single-Crystal XRD, Hirshfeld Analysis, and Cytotoxicity against A549 Cells.\",\"authors\":\"Yogeesha N Nayak, Deepika Dwarakanath, Keerthana Suresh Kizhakkanoodan, Rajeev K Sinha, K Sreedhara Ranganath Pai, Bharath Raja Guru, Santosh L Gaonkar\",\"doi\":\"10.1021/acsomega.5c02152\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>A new series of pyridine-based 1,3,4-oxadiazole derivatives was synthesized and structurally characterized using FTIR, NMR, HRMS, and single-crystal X-ray diffraction. Hirshfeld surface analysis of the meta-methyl-substituted derivative revealed key intermolecular interactions. Cytotoxicity was evaluated against A549 lung cancer cells via MTT assay, where compound <b>5k</b> (3,5-dichloro substitution) showed the highest activity (IC<sub>50</sub> = 6.99 ± 3.15 μM), comparable to 5-fluorouracil. Structure-activity relationship analysis indicated that meta-substituents enhance activity, while bulky or strongly electron-withdrawing groups reduce it. In silico studies demonstrated favorable ADME properties, and molecular docking with CDK2 revealed strong binding affinities. Molecular dynamics simulations confirmed the stability of the 5k-CDK2 complex over 100 ns. These findings suggest that pyridine-oxadiazole hybrids, particularly <b>5k</b>, are promising candidates for further development as anticancer agents.</p>\",\"PeriodicalId\":22,\"journal\":{\"name\":\"ACS Omega\",\"volume\":\"10 22\",\"pages\":\"23549-23562\"},\"PeriodicalIF\":4.3000,\"publicationDate\":\"2025-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12163846/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ACS Omega\",\"FirstCategoryId\":\"92\",\"ListUrlMain\":\"https://doi.org/10.1021/acsomega.5c02152\",\"RegionNum\":3,\"RegionCategory\":\"化学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/6/10 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"CHEMISTRY, MULTIDISCIPLINARY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Omega","FirstCategoryId":"92","ListUrlMain":"https://doi.org/10.1021/acsomega.5c02152","RegionNum":3,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/6/10 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
Unraveling Structural and Anticancer Properties of Pyridine-Oxadiazole Derivatives: Single-Crystal XRD, Hirshfeld Analysis, and Cytotoxicity against A549 Cells.
A new series of pyridine-based 1,3,4-oxadiazole derivatives was synthesized and structurally characterized using FTIR, NMR, HRMS, and single-crystal X-ray diffraction. Hirshfeld surface analysis of the meta-methyl-substituted derivative revealed key intermolecular interactions. Cytotoxicity was evaluated against A549 lung cancer cells via MTT assay, where compound 5k (3,5-dichloro substitution) showed the highest activity (IC50 = 6.99 ± 3.15 μM), comparable to 5-fluorouracil. Structure-activity relationship analysis indicated that meta-substituents enhance activity, while bulky or strongly electron-withdrawing groups reduce it. In silico studies demonstrated favorable ADME properties, and molecular docking with CDK2 revealed strong binding affinities. Molecular dynamics simulations confirmed the stability of the 5k-CDK2 complex over 100 ns. These findings suggest that pyridine-oxadiazole hybrids, particularly 5k, are promising candidates for further development as anticancer agents.
ACS OmegaChemical Engineering-General Chemical Engineering
CiteScore
6.60
自引率
4.90%
发文量
3945
审稿时长
2.4 months
期刊介绍：
ACS Omega is an open-access global publication for scientific articles that describe new findings in chemistry and interfacing areas of science, without any perceived evaluation of immediate impact.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
